Brookfield Business Partners L.P. (BBU)

Checkpoint Therapeutics Statistics

Total Valuation

BBU has a market cap or net worth of $5.37 billion. The enterprise value is $45.65 billion.

Market Cap	5.37B
Enterprise Value	45.65B

Important Dates

The last earnings date was Friday, August 1, 2025, before market open.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	Aug 29, 2025

Share Statistics

BBU has 212.67 million shares outstanding. The number of shares has decreased by -1.97% in one year.

Current Share Class	89.38M
Shares Outstanding	212.67M
Shares Change (YoY)	-1.97%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	93.41%
Float	42.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	10.86
PS Ratio	0.18
Forward PS	0.90
PB Ratio	2.34
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.52
EV / EBITDA	6.23
EV / EBIT	9.25
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 2.85.

Current Ratio	1.18
Quick Ratio	0.76
Debt / Equity	2.85
Debt / EBITDA	5.75
Debt / FCF	n/a
Interest Coverage	1.59

Financial Efficiency

Return on equity (ROE) is 6.07% and return on invested capital (ROIC) is 5.10%.

Return on Equity (ROE)	6.07%
Return on Assets (ROA)	3.93%
Return on Invested Capital (ROIC)	5.10%
Return on Capital Employed (ROCE)	8.01%
Revenue Per Employee	$418,097
Profits Per Employee	-$83
Employee Count	72,000
Asset Turnover	0.38
Inventory Turnover	4.93

Taxes

Income Tax	-101.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.22% in the last 52 weeks. The beta is 1.38, so BBU's price volatility has been higher than the market average.

Beta (5Y)	1.38
52-Week Price Change	+31.22%
50-Day Moving Average	25.38
200-Day Moving Average	23.74
Relative Strength Index (RSI)	50.54
Average Volume (20 Days)	30,563

Short Selling Information

Short Interest	7,989
Short Previous Month	8,711
Short % of Shares Out	0.00%
Short % of Float	0.02%
Short Ratio (days to cover)	0.60

Income Statement

In the last 12 months, BBU had revenue of $30.10 billion and -$6.00 million in losses. Loss per share was -$0.03.

Revenue	30.10B
Gross Profit	6.20B
Operating Income	4.93B
Pretax Income	252.00M
Net Income	-6.00M
EBITDA	7.33B
EBIT	4.93B
Loss Per Share	-$0.03

Balance Sheet

The company has $3.33 billion in cash and $43.61 billion in debt, giving a net cash position of -$40.28 billion or -$189.40 per share.

Cash & Cash Equivalents	3.33B
Total Debt	43.61B
Net Cash	-40.28B
Net Cash Per Share	-$189.40
Equity (Book Value)	15.32B
Book Value Per Share	10.77
Working Capital	2.52B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 20.60%, with operating and profit margins of 16.39% and -0.02%.

Gross Margin	20.60%
Operating Margin	16.39%
Pretax Margin	3.05%
Profit Margin	-0.02%
EBITDA Margin	24.35%
EBIT Margin	16.39%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $0.25, which amounts to a dividend yield of 0.99%.

Dividend Per Share	$0.25
Dividend Yield	0.99%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.97%
Shareholder Yield	2.96%
Earnings Yield	-0.11%
FCF Yield	n/a

Analyst Forecast

The average price target for BBU is $31.80, which is 25.89% higher than the current price. The consensus rating is "Buy".

Price Target	$31.80
Price Target Difference	25.89%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 15, 2022. It was a forward split with a ratio of 1.5:1.

Last Split Date	Mar 15, 2022
Split Type	Forward
Split Ratio	1.5:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	3